Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T03:20:16.976Z Has data issue: false hasContentIssue false
  • English
  • Français

The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review

Published online by Cambridge University Press:  16 April 2020

F Salomé ,
P Boyer  and
M Fayol
F Salomé*
Affiliation:
CNRS UMR 7593, Hôpital de la Pitié-Salpêtrière, 47, Boulevard de l’hôpital, 75651Paris, France
P Boyer
Affiliation:
CNRS UMR 7593, Hôpital de la Pitié-Salpêtrière, 47, Boulevard de l’hôpital, 75651Paris, France
M Fayol
Affiliation:
LAPSCO/CNRS, Université Blaise Pascal, 34 Avenue Carnot, 63037Clermont-Ferrand, France
*
*Correspondence and reprints. Email address: [email protected] (F. Salomé).
Get access

Extract

The aim of this survey is to present an overview of research into psychopharmacology as regards the effects of different psychoactive drugs and neuroleptics (NL) on language in normal subjects and schizophrenic patients. Eighteen studies that have investigated the effects of different drugs (alcohol, amphetamines, secobarbital, L-dopa, psilocybin, ketamine, fenfluramine) and neuroleptics (conventional and atypical) on language are reviewed. There are no studies concerning the effects of neuroleptics on language in healthy subjects. The results of the effects of other molecules indicate that language production can be increased (alcohol, amphetamine, secobarbital), rendered more complex (d-amphetamine), more focused (L-dopa) or more unfocused (psilocybin) and clearly impaired (ketamine). For schizophrenic patients, most studies show that conventional neuroleptic treatments, at a therapeutic dosage and in acute or chronic mode, reduce language disorders at all levels (clinic, linguistic, psycholinguistic). In conjunction with other molecules, the classical NL, when administered at a moderate dosage and in chronic mode, modify language in schizophrenia, either by improving the verbal flow and reducing pauses and positive thought disorder (NL + amphetamine) or by inducing an impairment in the language measurements (NL + fenfluramine). Clinical, methodological and theoretical considerations of results are debated in the framework of schizophrenic language disorders.

Keywords

languageneurolepticspsychoactive drugsschizophreniaspeechthought disorder
Type
Review
Information
European Psychiatry , Volume 15 , Issue 8 , December 2000 , pp. 461 - 469
Copyright
Copyright © 2001 Éditions scientifiques et médicales Elsevier SAS. All rights reserved

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abu-Akel, AA study of cohesive patterns and dynamic choices utilized by two schizophrenic patients in dialog, pre- and post medications Lang Speech 1997; 40: 331–351CrossRefGoogle Scholar
Adler, CGoldberg, TMalhotra, APickar, DBreier, AEffects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers Biol Psychiatry 1998; 43: 811–816CrossRefGoogle ScholarPubMed
Adler, CMalhotra, AElman, IGoldberg, TEgan, MPickar, D et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia Am J Psychiatry 1999; 156: 1646–1649CrossRefGoogle Scholar
Allen, HLiddle, PFrith, CNegative features, retrieval processes and verbal fluency in schizophrenia Br J Psychiatry 1993; 163: 769–775CrossRefGoogle Scholar
Alpert, MPouget, ESilson, CYahia, MAllan, EClinical and acoustic measures of the negative syndrome Psychopharmacol Bull 1995; 31: 321–326Google ScholarPubMed
Amand, AWales, RJackson, HVCopolov, DLLinguistic impairment in early psychosis J Nerv Ment Dis 1994; 182: 488–493CrossRefGoogle Scholar
Andreasen, NThought, language and communication disorder. 1: Clinical assessment, definition of terms and evaluation of reliability Arch Gen Psychiatry 1979; 36: 1315–1321CrossRefGoogle Scholar
Andreasen, NThought, language and communication disorder. 2: Diagnostic signifiance Arch Gen Psychiatry 1979; 36: 1325–1330CrossRefGoogle Scholar
Barch, DCarter, CBraver, TCohen, JThe effects of d-amphetamine on working memory and language deficits in schizophrenia Schizophr Res 1997; 24: 1–2CrossRefGoogle Scholar
Bilder, RLieberman, JKim, YAlvir, JReiter, GMethylphenidate and neuroleptic effects on oral word production in schizophrenia Neuropsychiatry, Neuropsychol Behav Neurol 1992; 5: 262–271Google Scholar
Bleuler, EDementia praecox ou groupe des schizophrénies 1993 EPEL, GREC ParisGoogle Scholar
Cassens, GInglis, AAppelbaum, PGutheil, TNeuroleptics: effects on neuropsychological function in chronic schizophrenic patients Schizophr Bull 1990; 16: 477–499CrossRefGoogle ScholarPubMed
Chaika, EUnderstanding psychotic speech: beyond Freud and Chomsky 1990 Charles C. Thomas SpringfieldGoogle Scholar
Clark, AHarvey, PAlpert, MMedication effects on referent communication in schizophrenic patients Brain Lang 1994; 46: 392–401CrossRefGoogle ScholarPubMed
Cohen, JServan-Schreiber, DTarg, ESpiegel, DThe fabric of thought disorder: a cognitive neuroscience approach to disturbances in the processing of context in schizophrenia Stein, DYoung, J 1992 Academic Press New YorkGoogle Scholar
Condray, RVan Kammen, DSteinhauer, SKaspareck, AYao, JLanguage comprehension in schizophrenia Biol Psychiatry 1995; 38: 287–296CrossRefGoogle Scholar
Corcoran, RFrith, CDConversational conduct and the symptoms of schizophrenia Cogn Neuropsychiatry 1996; 1: 305–318Google Scholar
Davidson, MKeefe, RCognitive impairment as a target for pharmacological treatment in schizophrenia Schizophr Res 1995; 17: 123–129CrossRefGoogle Scholar
Gold, JHurt, SThe effects of haloperidol on thought disorder and IQ in schizophrenia J Pers Assess 1990; 54: 390–400CrossRefGoogle Scholar
Goldberg, TWeinberger, DThought disorder, working memory and attention: interrelationships and the effects of neuroleptic medications Int Clin Psychopharmacol 10 Suppl 3 1995 99–104Google ScholarPubMed
Goldberg, TWeinberger, DEffects of neuroleptic medications on the cognition of patients with schizophrenia J Clin Psychiatry 57 Suppl 9 1996 62–65Google ScholarPubMed
Goldberg, TWeinberger, DThought disorder in schizophrenia: a reappraisal of older formulations and overview of some recent studies Cogn Neuropsychiatry 2000; 5: 1–19CrossRefGoogle Scholar
Goldsmith, SJoyce, SDopamine D2 receptors are organized in bands in human temporal cortex Neuroscience 1996; 74: 435–441CrossRefGoogle ScholarPubMed
Gottschalk, LThe application of computerized measurement of the content analysis of natural language to the assessment of the effects of psychoactive drugs Methods Find Exp Clin Pharmacol 1999; 21: 133–138CrossRefGoogle ScholarPubMed
Goren, ASwindell, CKhan, AExpressive language characteristics of schizophrenic subjects with different medication histories J Neuroling 1992; 7: 67–90CrossRefGoogle Scholar
Green, JKing, DCognitive functioning in schizophrenia: effects of drug treatments CNS Drugs 1996; 6: 382–398CrossRefGoogle Scholar
Higgins, SStitzer, MEffects of alcohol on speaking in isolated humans Psychopharmacology 1988; 95: 189–194CrossRefGoogle ScholarPubMed
Higgins, SStitzer, MMonologue speech: effects of d-amphetamine, secobarbital and diazepam Pharmacol Biochem Behav 1989; 34: 609–618CrossRefGoogle ScholarPubMed
Hoffman, RStopeck, SAndreasen, NA comparative study of manic vs schizophrenic speech disorganization Arch Gen Psychiatry 1986; 43: 831–838CrossRefGoogle ScholarPubMed
Hymowitz, PSpohn, HThe effects of antipsychotic medication on the linguistic ability of schizophrenics J Nerv Ment Dis 1980; 168: 287–296CrossRefGoogle ScholarPubMed
Johnston, HHolzman, PAssessing schizophrenic thinking 1979 Jossey-Bass San FranciscoGoogle Scholar
King, DJThe effect of neuroleptics on cognitive and psychomotor function Br J Psychiatry 1990; 157: 799–811CrossRefGoogle ScholarPubMed
Kischka, UKammer, TMaier, SWeisbrod, MThimm, MSpitzer, MDopaminergic modulation of semantic network activation Neuropsychologia 1996; 34: 1107–1113CrossRefGoogle ScholarPubMed
Lathi, AHolcomb, HGao, XTamminga, CNMDA-sensitive glutamate antagonism: a human model for psychosis Neuropsychopharmacology 21 Suppl 6 1999 158–169Google Scholar
Levy, DSmith, MRobinson, DJody, DLeiner, GAlvir, J et al. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls Biol Psychiatry 1993; 34: 507–514CrossRefGoogle ScholarPubMed
Manschreck, TMaher, BMilavetz, JAnes, DWeisstein, CSchneyer, MSemantic priming in thought disordered schizophrenic patients Schizophr Res 1988; 1: 61–66CrossRefGoogle ScholarPubMed
Medalia, AGold, JMeniam, AThe effects of neuroleptics on neuropsychological test results of schizophrenia Arch Clin Neuropsychol 1988; 3: 249–271CrossRefGoogle Scholar
Meltzer, HThompson, PLee, MRanjan, RNeuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment Neuropsychopharmacology 14 Suppl 3 1996 27–33CrossRefGoogle ScholarPubMed
Meltzer, HMcGurk, SThe effects of clozapine, risperidone and olanzapine on cognitive function in schizophrenia Schizophr Bull 1999; 25: 233–255CrossRefGoogle Scholar
Mortimer, ACognitive function in schizophrenia – do neuroleptics make a difference? Pharmacol Biochem Behav 1997; 56: 789–795CrossRefGoogle Scholar
Price, CThe functional anatomy of word comprehension and production Trends Cogn Sci (2) 1998 281–288CrossRefGoogle Scholar
Rochester, SMartin, JCrazy talk: a study of the schizophrenic speakers 1979 Plenum Press New YorkCrossRefGoogle Scholar
Salamé, PDanion, JPeretti, SCuervo, CThe state of functioning of working memory in schizophrenia Schizophr Res 1998; 30: 11–29CrossRefGoogle Scholar
Salomé, FBoyer, PPlanification et valence affective dans la production discursive de patients schizophrènes Ann Méd-Psychol 1999; 157: 743–748Google Scholar
Servan-Schreiber, DCohen, JStroop task, language and neuromodulation: models of cognitive deficits in schizophreniaParks, R et al. Fundamentals of neural network modeling: neuropsychology and cognitive neuroscience 1998 MIT Press Cambridge192–208Google Scholar
Sharma, TMockler, DThe cognitive efficacy of atypical antipsychotics in schizophrenia J Clin Psychopharmacol 18 Suppl 1 1998 12–19CrossRefGoogle Scholar
Soper, HElliott, RRezzer, AMarshall, BEffects of fenfluramine on neuropsychological and communicative functioning in treatment-refractory schizophrenic patients J Clin Psychopharmacol 1990; 10: 168–175Google ScholarPubMed
Spitzer, MThimm, MHermle, LHolzmann, PKovar, KAHeimann, H et al. Increased activation of indirect semantic associations under psilocybin Biol Psychiatry 1996; 39: 1055–1057CrossRefGoogle ScholarPubMed
Spitzer, MA cognitive neuroscience view of schizophrenic thought disorder Schizophr Bull 1997; 23: 29–50CrossRefGoogle ScholarPubMed
Spohn, HCoyne, LLarson, JMittleman, FSpray, JHayes, KEpisodic and residual thought pathology in chronic schizophrenia: effects of neuroleptics Schizophr Bull 1986; 12: 394–407CrossRefGoogle ScholarPubMed
Spohn, HStrauss, MRelation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia J Abnorm Psychol 1989; 98: 367–380CrossRefGoogle Scholar
Thomas, PLeudar, INapier, EKearney, GEllis, ERing, N et al. Syntactic complexity and negative symptoms in first onset schizophrenia Cogn Neuropsychiatry 1996; 1: 191–200CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.